Estimating drinking water PFAS exposures associated with serum clinical action levels using a probabilistic toxicokinetic model

Abstract

Consumption of drinking water is a major and actionable human exposure pathway for per- and polyfluoroalkyl substances (PFAS), making it a focus of regulatory efforts. Population-based clinical guidelines recently established serum PFAS levels associated with health risk, but translating these into corresponding external drinking water exposure concentrations remains a data gap. Toxicokinetic (TK) models that relate drinking water PFAS concentrations to population serum levels provide a framework to link clinical guidelines with environmental exposure. In this study, we expand and evaluate a probabilistic, one-compartment TK model to estimate population serum PFAS concentrations for six regulated PFAS. We implement the model to estimate drinking water PFAS concentrations that maintain serum concentrations in sensitive populations below a clinical action level recommended by the National Academies of Sciences, Engineering and Medicine. Model revisions include incorporating population variability distributions for exposure factors, implementing continuous modeling from birth to account for transgenerational transfer, improving computational efficiency, and adding two additional PFAS. Distributions of modifiable parameters are combined using Monte Carlo simulations to predict the distribution of serum PFAS concentrations across defined populations. Model predictions reproduced empirical serum concentrations for populations of infants, children, and adults within two-fold error of observed central tendencies and upper percentiles for six PFAS. Drinking water concentrations that maintain serum concentrations below the National Academies of Sciences, Engineering, and Medicine clinical action level for breastfed infants range from 19 to 162 ng/L for the six PFAS, individually. These drinking water concentrations can inform regulatory, policy, and clinical decision-making, although they are not appropriate as health-protective drinking water standards.

Keywords

Per- and polyfluoroalkyl substances / drinking water exposure / toxicokinetic modeling / regulatory decision-making / transgenerational transfer

References

[1] Glüge J,Cousins IT.An overview of the uses of per- and polyfluoroalkyl substances (PFAS).Environ Sci Processes Impacts2020;22:2345-73 PMCID:PMC7784712

[2] Calafat AM,Kuklenyik Z,Needham LL.Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.Environ Health Perspect2007;115:1596-602 PMCID:PMC2072821

[3] Nelson JW,Webster TF.Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population.Environ Health Perspect2010;118:197-202 PMCID:PMC2831917

[4] Winquist A.Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts.Environ Health Perspect2014;122:1299-305 PMCID:PMC4256699

[5] Schlezinger J,Sinioja T.Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPARα mice fed an American diet.Toxicol Appl Pharmacol2021;426:115644 PMCID:PMC8338894

[6] Ward-Caviness CK,Weaver A,Diaz-Sanchez D.Associations between PFAS occurrence and multimorbidity as observed in an electronic health record cohort.Environ Epidemiol2022;6:e217 PMCID:PMC9374186

[7] Nian M,Bloom M.Liver function biomarkers disorder is associated with exposure to perfluoroalkyl acids in adults: isomers of C8 Health Project in China.Environ Res2019;172:81-8

[8] Baumert BO,Walker DI.Translational framework linking perfluoroheptanoic acid (PFHpA) exposure to metabolic dysfunction associated steatotic liver disease in adolescents.Commun Med2025;5:430 PMCID:PMC12572386

[9] Sagiv SK,Fleisch AF.Early-pregnancy plasma concentrations of perfluoroalkyl substances and birth outcomes in project Viva: confounded by pregnancy hemodynamics?.Am J Epidemiol2018;187:793-802 PMCID:PMC5884712

[10] Wikström S,Lindh CH,Bornehag C.Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight.Pediatr Res2019;87:1093-9 PMCID:PMC7196936

[11] Budtz-Jørgensen E.Application of benchmark analysis for mixed contaminant exposures: mutual adjustment of perfluoroalkylate substances associated with immunotoxicity.PLoS ONE2018;13:e0205388 PMCID:PMC6195268

[12] Zahm S,Chiu WA.Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid.Lancet Oncol2024;25:16-7 PMCID:PMC12183505

[13] MassDEP. Per- and polyfluoroalkyl substances (PFAS): an updated subgroup approach to groundwater and drinking water values. 2019. https://www.mass.gov/doc/per-and-polyfluoroalkyl-substances-pfas-an-updated-subgroup-approach-to-groundwater-and/download. (accessed 2026-07-10)

[14] Dewitt JC,Schaider LA.Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: epidemiological and toxicological evidence.J Expo Sci Environ Epidemiol2018;29:148-56 PMCID:PMC6380927

[15] Kaye E,Agudelo Areiza J,Slitt A.Exposure to a PFOA, PFOS and PFHxS mixture during gestation and lactation alters the liver proteome in offspring of CD-1 mice.Toxics2024;12:348 PMCID:PMC11126053

[16] Appel M,Ramos R.The transplacental transfer efficiency of per- and polyfluoroalkyl substances (PFAS): a first meta-analysis.J Toxicol Environ Health B Crit Rev2021;25:23-42

[17] Midasch O,Hart N,Angerer J.Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study.Int Arch Occup Environ Health2007;80:643-8

[18] Goeden HM,Jacobus JA.A transgenerational toxicokinetic model and its use in derivation of Minnesota PFOA water guidance.J Expo Sci Environ Epidemiol2019;29:183-95 PMCID:PMC6760606

[19] Kingsley SL,Kelsey KT.Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood.Environ Res2018;165:247-57 PMCID:PMC6309672

[20] Van Beijsterveldt, I. A.; Van Zelst, B. D.; De Fluiter, K. S.; Van Den Berg, S. A.; Van Der Steen, M.; Hokken-Koelega, A. C. Poly- and perfluoroalkyl substances (PFAS) exposure through infant feeding in early life.Environ Int2022;164:107274

[21] Zheng G,Dempsey JC.Per- and polyfluoroalkyl substances (PFAS) in breast milk: concerning trends for current-use PFAS.Environ Sci Technol2021;55:7510-20

[22] De Silva AO,Bruton TA.PFAS exposure pathways for humans and wildlife: a synthesis of current knowledge and key gaps in understanding.Environ Toxicol Chem2021;40:631-57 PMCID:PMC7906948

[23] Deluca NM,Mullikin A,Cohen Hubal EA.Human exposure pathways to poly- and perfluoroalkyl substances (PFAS) from indoor media: a systematic review.Environ Int2022;162:107149 PMCID:PMC11577573

[24] EFSA Panel on Contaminants in the Food Chain (EFSA CONTAM Panel).Schrenk DBignami MBodin Let alRisk to human health related to the presence of perfluoroalkyl substances in food.EFSA J2020;18:e06223 PMCID:PMC7507523

[25] Haug LS,Brantsæter AL.Diet and particularly seafood are major sources of perfluorinated compounds in humans.Environ Int2010;36:772-8

[26] Vestergren R.12 - Human dietary exposure to per- and poly-fluoroalkyl substances (PFASs). In Persistent organic pollutants and toxic metals in foods. Woodhead Publishing; 2013. pp. 279-307.

[27] Haug LS,Schlabach M,Thomsen C.Investigation on per- and polyfluorinated compounds in paired samples of house dust and indoor air from norwegian homes.Environ Sci Technol2011;45:7991-8

[28] Holder C,Luh J,Melnyk LJ.Systematic evidence mapping of potential correlates of exposure for per- and poly-fluoroalkyl substances (PFAS) based on measured occurrence in biomatrices and surveys of dietary consumption and product use.Int J Hyg Environ Health2024;259:114384 PMCID:PMC11874334

[29] Pennoyer EH,Heiger-Bernays W.Exposure to legacy per- and polyfluoroalkyl substances from diet and drinking water in California adults, 2018-2020.Environ Sci Technol2025;59:9896-906 PMCID:PMC12120991

[30] Hu XC,Liddie J.Tap water contributions to plasma concentrations of poly- and perfluoroalkyl substances (PFAS) in a nationwide prospective cohort of U.S. women.Environ Health Perspect2019;127:067006 PMCID:PMC6792361

[31] Hurley S,Goldberg D.Preliminary associations between the detection of perfluoroalkyl acids (PFAAs) in drinking water and serum concentrations in a sample of California women.Environ Sci Technol Lett2016;3:264-9

[32] Shin H,Ryan PB,Bartell SM.Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project.Environ Health Perspect2011;119:1760-5 PMCID:PMC3261988

[33] Hoffman K,Bartell SM,Fletcher T.Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility.Environ Health Perspect2011;119:92-7 PMCID:PMC3018506

[34] Graber JM,Laumbach RJ.Per and polyfluoroalkyl substances (PFAS) blood levels after contamination of a community water supply and comparison with 2013-2014 NHANES.J Expo Sci Environ Epidemiol2018;29:172-82 PMCID:PMC6380951

[35] Xu Y,Li Y.Serum perfluoroalkyl substances in residents following long-term drinking water contamination from firefighting foam in Ronneby, Sweden.Environ Int2021;147:106333

[36] Daly ER,Talbot EA.Per- and polyfluoroalkyl substance (PFAS) exposure assessment in a community exposed to contaminated drinking water, New Hampshire, 2015.Int J Hyg Environ Health2018;221:569-77

[37] Landsteiner A,Johnson J.Biomonitoring for perfluorochemicals in a Minnesota community with known drinking water contamination.J Environ Health2014;77:14-9

[38] Cserbik D,Flores C.Concentrations of per- and polyfluoroalkyl substances (PFAS) in paired tap water and blood samples during pregnancy.J Expo Sci Environ Epidemiol2023;34:90-6 PMCID:PMC10907290

[39] Post GB.Recent US State and Federal drinking water guidelines for per- and polyfluoroalkyl substances.Environ Toxicol Chem2021;40:550-63

[40] USEPA. Per- and polyfluoroalkyl substances national primary drinking water regulation [EPA-HQ-OW-2022-0114]. 2024. https://www.regulations.gov/document/EPA-HQ-OW-2022-0114-3076. (accessed 2026-07-10)

[41] USEPA. Rescission of regulatory determinations and removal of related provisions for four PFAS substances (PFHxS, PFNA, HFPO-DA (GenX), and the mixture of these three PFAS plus PFBS) [EPA-HQ-OW-2025-0654; FRL 12843-01-OW]. 2026. https://www.govinfo.gov/content/pkg/FR-2026-05-20/pdf/2026-10085.pdf. (accessed 2026-07-10)

[42] National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Division on Earth and Life Studies; Board on Population Health and Public Health Practice; Board on Environmental Studies and Toxicology; Committee on the Guidance on PFAS Testing and Health Outcomes. Guidance on PFAS exposure, testing, and clinical follow-up. Washington, D.C.: National Academies Press; 2022.

[43] Lynch MT,Sokolinski S.Community-facing toxicokineticmodels to estimate PFAS serum levels based on life history and drinking water exposures.Environ Int2023;176:107974 PMCID:PMC11017972

[44] Chiu WA,Lay CR.Bayesian estimation of human population toxicokinetics of PFOA, PFOS, PFHxS, and PFNA from studies of contaminated drinking water.Environ Health Perspect2022;130:127001 PMCID:PMC9714558

[45] USEPA. Perfluorodecanoic acid (PFDA) [CASRN 335-76-2]. Toxicological review of perfluorodecanoic acid (PFDA) and related salts (Final Report, 2024). https://iris.epa.gov/document/&deid=361797. (accessed 2026-07-10)

[46] Dawson DE,Pradeep P.A machine learning model to estimate toxicokinetic half-lives of per- and polyfluoro-alkyl substances (PFAS) in multiple species.Toxics2023;11:98 PMCID:PMC9962572

[47] Ohmori K,Katayama K.Toxicology 2003;184:135-40.

[48] Kabadi SV,Aungst J.Internal exposure-based pharmacokinetic evaluation of potential for biopersistence of 6:2 fluorotelomer alcohol (FTOH) and its metabolites.Food Chem Toxicol2018;112:375-82

[49] Greene CW,Goeden HM.A revised and improved toxicokinetic model to simulate serum concentrations of bioaccumulative PFAS.J Environ Expo Assess2024;3:12

[50] Zheng P,An Q.Prenatal and postnatal exposure to emerging and legacy per-/polyfluoroalkyl substances: levels and transfer in maternal serum, cord serum, and breast milk.Sci Total Environ2022;812:152446

[51] Mahfouz M,Matta J.Maternal serum, cord and human milk levels of per- and polyfluoroalkyl substances (PFAS), association with predictors and effect on newborn anthropometry.Toxics2023;11:455 PMCID:PMC10223184

[52] Blomberg AJ,Lindh C.Changes in perfluoroalkyl substances (PFAS) concentrations in human milk over the course of lactation: a study in Ronneby mother-child cohort.Environ Res2023;219:115096

[53] USEPA. Update for Chapter 3 of the Exposure Factors Handbook: Ingestion of water and other select liquids. 2019. https://www.epa.gov/sites/default/files/2019-02/documents/efh_-_chapter_3_update.pdf. (accessed 2026-07-10)

[54] USEPA. Exposure Factors Handbook: Chapter 15 - Human milk intake. 2011. https://www.epa.gov/system/files/documents/2025-01/efh-chapter15_508.pdf. (accessed 2026-07-10)

[55] Belgorodski N,Tolksdorf K,Flor M. Package ‘rriskDistributions’: fitting distributions to given data or known quantiles. ver.2.1.2, 2017. https://cran.r-project.org/web/packages/rriskDistributions/rriskDistributions.pdf. (accessed 2026-07-10)

[56] USEPA. Methodology for deriving ambient water quality criteria for the protection of human health (2000) [EPA 822-B-00-004]. 2000. https://19january2021snapshot.epa.gov/sites/static/files/2018-10/documents/methodology-wqc-protection-hh-2000.pdf. (accessed 2026-07-10)

[57] USEPA. 2018 Edition of the Drinking Water Standards and Health Advisories Tables [EPA 822-F-18-001]. 2018. https://www.epa.gov/system/files/documents/2022-01/dwtable2018.pdf. (accessed 2026-07-10)

[58] R Core Team. R: a language and environment for statistical computing. ver.4.5.1. 2025. https://www.R-project.org/. (accessed 2026-07-10)

[59] Morris TP,Crowther MJ.Using simulation studies to evaluate statistical methods.Stat Med2019;38:2074-102 PMCID:PMC6492164

[60] Hölzer J,Rauchfuss K.Biomonitoring of perfluorinated compounds in children and adults exposed to perfluorooctanoate-contaminated drinking water.Environ Health Perspect2008;116:651-7 PMCID:PMC2367678

[61] Babayev M,Miller P.PFAS in drinking water and serum of the people of a southeast Alaska community: a pilot study.Environ Pollut2022;305:119246 PMCID:PMC9090981

[62] Hall SM,Tait GH.PFAS levels in paired drinking water and serum samples collected from an exposed community in Central North Carolina.Sci Total Environ2023;895:165091 PMCID:PMC10529814

[63] Criswell RL,Chatterjee M,Diaz S.Quantifying levels of per- and polyfluoroalkyl substances (PFAS) in water and serum after contamination from agricultural biosolid application.Environ Int2024;190:108850

[64] Fromme H,Morovitz M.Pre- and postnatal exposure to perfluorinated compounds (PFCs).Environ Sci Technol2010;44:7123-9

[65] Varsi K,Huber S,Brox J.Impaired gross motor development in infants with higher PFAS concentrations.Environ Res2022;204:112392

[66] Bartell SM.Online serum PFOA calculator for adults.Environ Health Perspect2017;125:104502 PMCID:PMC5933303

[67] Arzuaga, X.; Druwe, I. L.; Bateson, T. F.; et al. IRIS toxicological review of perfluorohexanesulfonic acid (PFHxS, CASRN 335-46-4) and related salts. Washington (DC): U.S. Environmental Protection Agency; 2025. https://www.ncbi.nlm.nih.gov/books/NBK614202/. (accessed 2026-07-10)

[68] USEPA. Human health toxicity assessment for perfluorooctanoic acid (PFOA) and related salts, final [815R24006]. 2024. https://www.epa.gov/system/files/documents/2024-05/final-human-health-toxicity-assessment-pfoa.pdf. (accessed 2026-07-10)

[69] USEPA. Human health toxicity assessment for perfluorooctane sulfonic acid (PFOS) and related salts, final [815R24007] 2024. https://www.epa.gov/system/files/documents/2024-05/final-human-health-toxicity-assessment-pfos.pdf. (accessed 2026-07-10)

[70] USEPA. IRIS toxicological review of perfluorononanoic acid (PFNA) and related salts (Public Comment and External Review Draft) [EPA/635/R-24/031a] 2024. https://assessments.epa.gov/risk/document/&deid%3D355409. (accessed 2026-07-10)

[71] USEPA. Maximum contaminant level goals (MCLGs) for three individual per- and polyfluoroalkyl substances (PFAS) and a mixture of four PFAS, final [EPA-815-R-24-004]. 2024. https://www.epa.gov/system/files/documents/2024-04/pfas-hi-mclg_final508.pdf. (accessed 2026-07-10)

[72] USEPA. Guidelines for the health risk assessment of chemical mixtures [EPA/630/R-98/002]. 1986. https://www.epa.gov/sites/default/files/2014-11/documents/chem_mix_1986.pdf. (accessed 2026-07-10)

[73] USEPA. Supplementary guidance for conducting health risk assessment of chemical mixtures [EPA/630/R-00/002]. 2000. https://ordspub.epa.gov/ords/eims/eimscomm.getfile?p_download_id=4486. (accessed 2026-07-10)

[74] Mogensen UB,Nielsen F,Budtz-Jørgensen E.Breastfeeding as an exposure pathway for perfluorinated alkylates.Environ Sci Technol2015;49:10466-73 PMCID:PMC6190571

[75] Koponen J,Airaksinen R.Longitudinal trends of per- and polyfluoroalkyl substances in children’s serum.Environ Int2018;121:591-9

[76] Mondal D,Armstrong BG.Breastfeeding: a potential excretion route for mothers and implications for infant exposure to perfluoroalkyl acids.Environ Health Perspect2014;122:187-92 PMCID:PMC3915259

[77] Papadopoulou E,Namork E,Granum B.Exposure of Norwegian toddlers to perfluoroalkyl substances (PFAS): the association with breastfeeding and maternal PFAS concentrations.Environ Int2016;94:687-94

[78] Vannoy BN,Zota AR.Breastfeeding as a predictor of serum concentrations of per- and polyfluorinated alkyl substances in reproductive-aged women and young children: a rapid systematic review.Curr Environ Health Rep2018;5:213-24

[79] Pétré MA,Stapleton HM.Per- and polyfluoroalkyl substances (PFAS) in river discharge: modeling loads upstream and downstream of a PFAS manufacturing plant in the Cape Fear watershed, North Carolina.Sci Total Environ2022;831:154763

[80] Johanson G,Ekstrand C.Quantitative relationships of perfluoroalkyl acids in drinking water associated with serum concentrations above background in adults living near contamination hotspots in Sweden.Environ Res2023;219:115024

[81] Zhang S,Peng H.Relationship between perfluorooctanoate and perfluorooctane sulfonate blood concentrations in the general population and routine drinking water exposure.Environ Int2019;126:54-60

[82] Bogdan AR,Goeden H.Estimation of serum PFOA concentrations from drinking and non–drinking water exposures.Environ Health Perspect2023;131:067701 PMCID:PMC10275357

[83] McDonough CA,Barton KE.Unsaturated PFOS and other PFASs in human serum and drinking water from an AFFF-impacted community.Environ Sci Technol2021;55:8139-48

[84] Lewis-Michl EL,Hsu W.Perfluorooctanoic acid serum concentrations and half-lives in a community exposed to contaminated drinking water in New York State.J Expo Sci Environ Epidemiol2025;35:403-13 PMCID:PMC12069094

[85] Xu Y,Pineda D.Serum half-lives for short- and long-chain perfluoroalkyl acids after ceasing exposure from drinking water contaminated by firefighting foam.Environ Health Perspect2020;128:077004 PMCID:PMC7351026

[86] Emmett EA,Zhang H,Desai C.Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources.J Occup Environ Med2006;48:759-70 PMCID:PMC3038253

[87] Post GB,Cooper KR,Lippincott RL.Occurrence and potential significance of perfluorooctanoic acid (PFOA) detected in New Jersey public drinking water systems.Environ Sci Technol2009;43:4547-54